PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
CignaAll Plans · Prior Auth · Pharmacy · Oncology, Hematology, PharmacyHigh impact

Specialty Medical Injectables with Reimbursement Restriction

Act
by Jan 1, 2027
Effective date
Not stated in the notice
Identified
Oct 10, 2026

Summary

Cigna Healthcare has expanded its Specialty Medical Injectables with Reimbursement Restriction list, requiring that certain injectables be dispensed and claims submitted through a Cigna-contracted specialty pharmacy when administered in outpatient hospital settings. One drug (Zanvastro) is already restricted as of September 28, 2026, and 11 additional drugs become restricted effective January 1, 2027. The restriction does not apply to injectables administered in provider offices, non-hospital ambulatory infusion suites, or home settings.

Get alerts when payers change rules like this one

We check Cigna and other payers every day and email you when a change matches your specialty and state.

Get Cigna alertsPolicy Monitoring is free. No card required.

What to do

by Jan 1, 2027 · 5 steps
01Billing and clinical staff must verify that all claims for the 11 newly restricted injectables (Blincyto, Datroway, Imdelltra, Jelmyto, Keytruda, Lynozyfic, Rylplazim, Talvey, Texcayli, Unloxcyt, Zusduri) administered in outpatient hospital settings are submitted exclusively through Cigna-contracted specialty pharmacies unless explicitly authorized by Cigna Healthcare.
02Immediately (for September 28, 2026 effective date): Verify that Zanvastro claims from outpatient hospital settings are being routed through a Cigna-contracted specialty pharmacy.
03Billing team should update internal protocols to distinguish between outpatient hospital administration (requires specialty pharmacy routing) and office/non-hospital ambulatory/home administration (no restriction).
04Review the full Specialty Medical Injectables with Reimbursement Restriction list regularly at CignaforHCP.com > Resources > Reimbursement and Payment Policies > Precertification Policies to identify any additional drug additions.
05Claims submitted outside this requirement may be denied or face reimbursement restrictions.

Original notice

Specialty Medical Injectables with Reimbursement Restriction
providernewsroom.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account